Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus

Keyphrases

• Type 2 Diabetes Mellitus (T2DM) 100%
• Once-daily 100%
• Liraglutide 100%
• Type 2 Diabetes Prevention 100%
• GLP-1 Analogue 100%
• Glucagon-like 40%
• Adverse Events 20%
• A1 Receptor 20%
• Hemoglobin A1c (HbA1c) 20%
• Type 2 Diabetic Patients 20%
• β-cell Function 20%
• Clinical Development 20%
• Once-daily Dosing 20%
• Nausea 20%
• Mechanism of Action 20%
• Weight Reduction 20%
• Diarrhea 20%
• Insulin Secretion 20%
• Fatty Acids 20%
• Incretin Hormones 20%
• Intestinal Peptides 20%
• Receptor Analog 20%
• Pharmacokinetic Properties 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Insulin Dependent Diabetes Mellitus 100%
• Liraglutide 100%
• Glucagon-Like Peptide-1 100%
• Adverse Event 20%
• Pharmacokinetics 20%
• Nausea 20%
• Incretin 20%
• Fatty Acid 20%
• Diarrhea 20%
• Glucagon-Like Peptide 1 Receptor 20%